Release Date: 06/02/19 09:56 Summary: RMS: Ramelius reaches 90% relevant interest in Explaurum Price Sensitive: Yes Download Document Not available as of the moment. Download
RBL Recce Pharmaceuticals advances global reach with Indonesia’s approval for Phase 3 Diabetic Foot Infection Trial